Cynata confirms receipt of indicative non-binding proposal
Filed with ASX · · 1 page · English
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- June 2019 Quarterly Report
- Cynata Strengthens Board & Executive Management Team
- March 2019 Quarterly Report
- Cynata Extends FUJIFILM Licence Option in GvHD
- Cynata Receives Favourable Advice on Planned CLI Trial
Later from Cynata Therapeutics
- Response to ASX Price and Volume Query
- Response to ASX Aware Query
- Update on Discussions with Sumitomo and Fujifilm
- Fujifilm Exercises License Option in GvHD
- Cynata Receives US$3 million Fujifilm License Fee
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics